本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioRestorative Therapies, Inc.

1.75
-0.1600-8.38%
成交量:1.14万
成交额:2.07万
市值:241.70万
市盈率:-0.08
高:1.90
开:1.85
低:1.70
收:1.91
52周最高:34.40
52周最低:1.70
股本:138.11万
流通股本:124.91万
量比:0.18
换手率:0.91%
股息:- -
股息率:- -
每股收益(TTM):-21.7566
每股收益(LYR):-31.6731
净资产收益率:-241.14%
总资产收益率:-118.81%
市净率:0.80
市盈率(LYR):-0.06

数据加载中...

2021/11/16

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/15

重要事件披露

8-K - Current report
2021/11/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/08

重要事件披露

8-K - Current report
2021/11/04

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/11/04

SEC问询函

CORRESP [Cover] - Correspondence
2021/11/04

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/29

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/26

重要事件披露

8-K - Current report
2021/10/20

重要事件披露

8-K - Current report
2021/10/18

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/08/17

重要事件披露

8-K - Current report
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/06

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/05/17

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/05

重要事件披露

8-K/A [Amend] - Current report